Clinical Trials Browser

Phase 1/2 × INDUSTRY × Adenoviridae Infections × Clear all

NCT05271318 2026-05-05

PROTA

Phase 1/2 Active not recruiting

Adenoviridae Infections

NCT06763965 2026-03-23

Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.

Phase 1/2 Enrolling by invitation

Adenoviridae Infections, Glioma

NCT02705196 2026-02-24

LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer

Phase 1/2 Completed

Gastrointestinal

Adenoviridae Infections, Neoplasms, Pancreatic Neoplasms

NCT03754933 2025-03-27

Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer

Phase 1/2 Completed

10 enrolled 22 charts

Squamous Cell Carcinoma of Head and Neck, Adenoviridae Infections, Head and Neck Neoplasms

NCT04097002 2023-10-31

First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients.

Phase 1/2 Unknown

Adenoviridae Infections, Prostatic Neoplasms

NCT01570283 2019-05-30

ARMS

Phase 1/2 Completed

21 enrolled 10 charts

Adenoviridae Infections, Virus Diseases, Epstein-Barr Virus Infections

NCT02844699 2017-09-20

A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer

Phase 1/2 Unknown

Alzheimer Disease 5, Adenoviridae Infections, Prostatic Neoplasms